Dianthus Therapeutics, Inc. (DNTH)
108.10
+0.25
(+0.23%)
USD |
NASDAQ |
Sep 04, 16:00
107.92
-0.18
(-0.17%)
After-Hours: 20:00
Dianthus Therapeutics Research and Development Expense (Quarterly) : 48.69M for June 30, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 48.69M |
| March 31, 2026 | 34.53M |
| December 31, 2025 | 59.90M |
| September 30, 2025 | 32.49M |
| June 30, 2025 | 26.25M |
| March 31, 2025 | 27.00M |
| December 31, 2024 | 26.41M |
| September 30, 2024 | 25.54M |
| June 30, 2024 | 18.07M |
| March 31, 2024 | 13.08M |
| December 31, 2023 | 8.781M |
| September 30, 2023 | 7.96M |
| June 30, 2023 | 10.25M |
| March 31, 2023 | 5.847M |
| December 31, 2022 | 9.831M |
| September 30, 2022 | 7.218M |
| June 30, 2022 | 10.41M |
| March 31, 2022 | 15.34M |
| December 31, 2021 | 12.58M |
| Date | Value |
|---|---|
| September 30, 2021 | 10.26M |
| June 30, 2021 | 10.65M |
| March 31, 2021 | 11.25M |
| December 31, 2020 | 11.76M |
| September 30, 2020 | 11.29M |
| June 30, 2020 | 12.12M |
| March 31, 2020 | 13.47M |
| December 31, 2019 | 18.23M |
| September 30, 2019 | 16.52M |
| June 30, 2019 | 13.43M |
| March 31, 2019 | 10.54M |
| December 31, 2018 | 12.39M |
| September 30, 2018 | 11.42M |
| June 30, 2018 | 9.683M |
| March 31, 2018 | 7.849M |
| December 31, 2017 | 5.551M |
| September 30, 2017 | 5.21M |
| June 30, 2017 | 13.82M |
| March 31, 2017 | 3.322M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Legend Biotech Corp. | 96.16M |
| Ironwood Pharmaceuticals, Inc. | 21.96M |
| Verastem, Inc. | 41.34M |
| Fortress Biotech, Inc. | 0.805M |
| AbbVie, Inc. | 2.344B |